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Abstract
Objective: To assess the scores of postpartum women using the WHO Disability 
Assessment	Schedule	2.0	36-	item	tool	(WHODAS-	36),	considering	different	morbidities.
Methods:	Secondary	analysis	of	a	 retrospective	cohort	of	women	who	delivered	at	a	
referral	maternity	in	Brazil	and	were	classified	with	and	without	severe	maternal	morbid-
ity	(SMM).	WHODAS-	36	was	used	to	assess	functioning	in	postpartum	women.	Percentile	
distribution	 of	 total	WHODAS	 score	 was	 compared	 across	 three	 groups:	 Percentile	
(P)<10, 10<P<90, and P>90. Cases of SMM were categorized and WHODAS- 36 score 
was	assessed	according	to	hypertension,	hemorrhage,	or	other	conditions.
Results: A total of 638 women were enrolled: 64 had mean scores below P<10 (1.09) 
and 66 were above P>90 (41.3). Of women scoring above P>90, those with morbidity 
had a higher mean score than those without (44.6% vs 36.8%, P=0.879). Women with 
higher	WHODAS-	36	scores	presented	more	complications	during	pregnancy,	especially	
hypertension (47.0% vs 37.5%, P=0.09). Mean scores among women with any complica-
tion	were	higher	 than	those	with	no	morbidity	 (19.0	vs	14.2,	P=0.01). WHODAS- 36 
scores	 were	 higher	 among	 women	 with	 hypertensive	 complications	 (19.9	 vs	 16.0,	
P=0.004),	but	lower	among	those	with	hemorrhagic	complications	(13.8	vs	17.7,	P=0.09).
Conclusions:	Complications	during	pregnancy,	childbirth,	and	the	puerperium	increase	
long-	term	WHODAS-	36	 scores,	 demonstrating	 a	 persistent	 impact	 on	 functioning	
among women, up to 5 years postpartum.
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1  | INTRODUCTION
According	to	the	United	Nations	World	Report	on	Disability,	glob-
ally	 nearly	200	million	people	 experience	negative	 impacts	 on	 their	
functioning,	which	in	turn	creates	difficulties	in	their	economic	partic-
ipation,	health	access,	and	education	improvement.1	The	International	
Classification	of	Functioning,	Disability	and	Health	(ICF)	was	created	by	
the WHO2	to	assess	and	categorize	different	disabilities.	Instruments	
that	evaluate	disability	and	 functioning	must	be	 linked	conceptually	
and	operationally	to	the	ICF,	to	allow	comparisons	between	different	
populations	worldwide.	Addressing	pregnancy-	and	childbirth-	related	
short- and long- term disability among women is important in achiev-
ing	 women’s	 health-	related	 UN	 Sustainable	 Development	 Goals.3 
Daily,	 about	 800	women	die	 from	pregnancy-	related	 complications,	
but	for	each	death,	a	dozen	more	women	survive	but	may	suffer	last-
ing consequences.4 Severe maternal morbidity has been extensively 
studied,	with	standardized	definitions	for	potentially	 life-	threatening	
conditions	and	maternal	near	miss.5 Several women who survive will 
suffer	altered	functioning.6
The WHO Disability Assessment Schedule (WHODAS) 2.0 has 36 
items (or 32, for women not working or studying) and has been trans-
lated	 into	many	 languages	 for	cross-	cultural	adaptation.7 It is a psy-
chometric scale based on the conceptual framework of the ICF, and 
captures	individual	dysfunction	in	six	domains	of	daily	activities	(cog-
nition,	mobility,	self-	care,	relationships	with	people,	life	activities,	and	
participation).	The	total	score	ranges	from	0	to	100,	and	a	high	score	is	
indicative	of	a	greater	limitation	in	conducting	activities	of	daily	living.8 
The WHODAS 2.0 36- item version (WHODAS- 36) intends to mea-
sure	activity,	function,	and	participation	in	daily	living	activities	in	the	
30	days	preceding	its	application.9
Our group has previously studied postpartum women with and 
without a history of severe maternal morbidity (SMM) and concluded 
that	 there	 was	 a	 significant	 difference	 among	 groups	 evaluated	 by	
WHODAS- 36.10	However,	a	study	considering	the	impact	of	different	
underlying	causes	of	morbidities	on	WHODAS	scores	and	percentile	
results	has	not	been	performed,	and	a	better	understanding	of	the	con-
ditions	that	can	be	more	closely	related	to	future	disability	might	enable	
specific	interventions	to	improve	maternal	health	in	those	cases.
The aim of the present analysis was to assess the higher WHODAS 
scores	 (most	 likely	 revealing	 impaired	 functionality),	 considering	val-
ues	above	the	90th	percentile	(P>90),	among	women	with	a	history	of	
SMM,	according	to	the	underlying	morbidities	of	hypertension,	hem-
orrhage, and other (mostly indirect) causes of SMM.
2  | MATERIALS AND METHODS
We	performed	a	secondary	analysis	of	a	retrospective	cohort	of	women	
who delivered at a referral maternity hospital in Brazil. The methodolog-
ical details of the main study have been published elsewhere.10	Briefly,	
women who delivered between July 1, 2008, and June 30, 2012, at the 
Women’s	Hospital	of	 the	University	of	Campinas	were	 identified.	Of	
these, women who experienced SMM, according to the WHO criteria,5 
were eligible as the “exposed” group. A “nonexposed” group was com-
posed	of	women	without	SMM,	selected	randomly	in	a	1:1	ratio,	from	
a computer- generated list, by year of childbirth. The nonexposed group 
could include women with uncomplicated pregnancy and childbirth 
and women with nonsevere morbidity. Newborn outcomes were not 
considered	in	the	selection	of	women.	A	chart	review	was	performed	
for maternal and perinatal outcomes, and women were scheduled for 
a	 postpartum	 evaluation	 (ranging	 from	 1	 to	 5	years	 after	 delivery),	
including	 the	 36-	item	 WHODAS	 2.0	 questionnaire	 conducted	 by	
trained	interviewers	of	different	backgrounds	(doctors,	nurses,	and	psy-
chologists).	Women	who	participated	 in	 the	study	provided	 informed	
consent.10	The	study	was	approved	by	the	University	of	Campinas	insti-
tutional	review	board	(approval	number	447/2009).
Interviews	 were	 initially	 recorded	 on	 paper	 charts.	 Data	 entry	
was	done	on	a	virtual	database	specifically	built	 for	 the	study	using	
the	 LimeSurvey	 platform	 (www.limesurvey.org;	 LimeSurvey	 GmbH,	
Hamburg, Germany). Data were analyzed using SPSS version 2.0 (IBM, 
Armonk, NY, USA).
A total of 638 women were enrolled in the cohort, 315 in the 
exposed group and 323 in the nonexposed group. Groups had similar 
sociodemographic	characteristics.	In	our	current	analysis,	we	catego-
rized	the	percentile	distribution	of	WHODAS-	36	total	score	for	all	638	
women in the cohort. We further divided women into three groups: 
P<10	(women	with	scores	below	the	10th	percentile),	P>90	(women	
with	scores	above	the	90th	percentile),	and	10<P<90	(a	group	com-
posed	of	women	who	scored	between	the	10th	and	90th	percentiles).	
Data were compared using the t test and analysis of variance (ANOVA). 
A P	value	of	0.05	or	below	was	considered	statistically	significant.
Data	on	median,	mean,	and	standard	deviation	of	WHODAS-	36	
score	 were	 analyzed	 for	 the	 three	 groups.	 Within	 the	 percentile	
groups, women were then divided into two categories: those with 
and those without maternal morbidity. Furthermore, the women with 
morbidity	were	then	grouped	by	different	underlying	causes	of	mater-
nal morbidity: hypertensive disorders (including pre- eclampsia, gesta-
tional	hypertension,	and	chronic	hypertension),	hemorrhage,	or	other	
conditions	 (including	 obesity;	 low	weight;	 diabetes;	 smoking;	 heart,	
kidney, or pulmonary diseases; sickle cell anemia; HIV/AIDS; thyroid 
diseases; neurologic diseases/epilepsy; collagenosis; and cancer). The 
underlying	morbidities	were	 not	mutually	 exclusive,	 since	 the	 same	
woman	 could	 have	 more	 than	 one	 complication.	 It	 is	 important	 to	
note	that	for	the	current	analysis,	we	did	not	limit	conditions	to	those	
associated	with	SMM	 (the	presence	of	WHO	criteria	 for	potentially	
life-	threatening	 conditions	 [PLTC]	 and	 maternal	 near	 miss	 [MNM]),	
as	in	the	original	study;	instead	morbidity	was	defined	as	the	current	
broader	concept	of	maternal	morbidity,	defined	by	the	WHO	Maternal	
Morbidity Working Group.11
3  | RESULTS
The	 distribution	 of	 women	 included	 in	 this	 analysis	 is	 shown	 in	
Figure 1. The overall mean value of WHODAS- 36 scores among 
women	below	the	10th	percentile	 (n=64)	was	1.09	 (0.94–1.89)	and	
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for	 those	 in	 the	90th	percentile	 (n=66)	 it	was	41.30	 (36.96–44.52).	
Considering both groups, women with and without maternal morbid-
ity,	there	was	a	nonsignificant	trend	of	high	WHODAS	scores	(P>90)	
among cases with morbidity (44.6% vs 36.8%; P=0.879) (Table 1).
Women who presented with a history of maternal morbidity owing 
to	other	complications	(in	this	sample	this	represented	mostly	indirect	
causes	 of	 morbidity,	 especially	 infection,	 given	 the	 influenza	 H1N1	
outbreak	at	the	time	the	study	was	conducted)	were	significantly	more	
likely	 to	 have	 scores	 above	 the	 90th	 percentile	 (P=0.045; Table 2). 
The	 distribution	 of	 women	 with	 hemorrhagic	 complications	 across	
the	three	percentile	groups	(P<10,	P>90,	and	10<P<90)	according	to	
WHODAS-	36	 scores	was	 similar	 (Table	2).	Additionally,	we	 analyzed	
the incidence of 31 perinatal deaths (4.9% of the overall sample) across 
the	three	percentile	groups,	and	found	no	statistically	significant	dif-
ference	between	them	(7.8%,	4.8%,	and	3.3%,	respectively;	P<0.001).
The	occurrence	of	any	complication	or	the	presence	of	any	previ-
ous	medical	condition	impacted	postpartum	functioning,	as	shown	in	
Table	3.	Mean	scores	among	women	with	any	complication	were	higher	
than those with no morbidity (19.0 ± 16.4 vs 14.2 ± 13.3; P=0.01). 
Higher WHODAS- 36 scores were also seen in women who presented 
with	hypertension	or	other	complications	during	pregnancy,	but	not	
for	those	with	hemorrhagic	conditions	(19.9	±	16.6	vs	19.4	±	16.3	vs	
13.8 ± 13.8, P=0.01).
Each domain of the WHODAS- 36 was compared among the dif-
ferent underlying causes of maternal morbidity and results are shown 
in	Table	4.	 Scores	 for	 domains	 5	 (household	 activities),	 6	 (participa-
tion),	and	1	(cognition)	were	the	most	impacted	by	maternal	morbidity,	
while	domain	3	(self-	care)	was	the	least	affected.	However,	there	was	
no	statistically	significant	difference	among	the	underlying	causes	of	
maternal morbidity across any of the domains.
4  | DISCUSSION
Our	study	found	that	maternal	morbidity	negatively	impacted	postpar-
tum	functioning,	especially	in	women	with	hypertensive	disorders	of	
pregnancy and other indirect causes of maternal morbidity. Measuring 
health-	related	functioning	is	a	relatively	new	concern	and	WHODAS	
F IGURE  1 Flow chart of the distribution of women among the three percentile groups, according to their scores on the WHO Disability 
Assessment Schedule (WHODAS) 2.0 36- item tool.
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No 
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Complete WHODAS-36
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TABLE  1 WHODAS-	36	total	score	values	of	percentile	10	(P<10)	
and	percentile	90	(P>90)	for	women	with	maternal	morbidity	and	no	
morbidity.
P<10 P>90
No. 64 66
Total 1.1 (0.9–1.9) 41.3 (37.0–44.5)
No morbiditya 1.9 (1.1–1.9) 36.8 (32.6–42.4)
Maternal morbiditya 1.0 (0.0–2.0) 44.6 (39.6–48.3)
aCut-	off	 point	 for	 each	 percentile.	 Yates	 χ2 test used to compare both 
groups. P value for P<10=0.698; P value for P>90=0.879.
TABLE  2 Frequency	of	complications	during	pregnancy	according	
to	the	WHODAS-	36	score	among	three	different	percentile	groups.
Complications
P<10  
(n=64) 
No. (%)
10<P<90  
(n=501) 
No. (%)
P>90 
(n=66) 
No. (%) P value
None 22 (34.4) 178 (35.5) 14 (21.2) 0.069
Any 42 (65.6) 323 (64.5) 52 (78.8)
Hemorrhagea 4 (6.2) 48 (9.6) 3 (4.5) 0.30
Hypertensive 
disordersa
24 (37.5) 168 (33.5) 31 (47.0) 0.09
Othera,b 37 (57.8) 293 (58.5) 49 (74.2) 0.045
aCategories were not mutually exclusive.
bCategory included women with: obesity; low weight; diabetes; heart, kid-
ney, or pulmonary diseases; sickle cell anemia; HIV/AIDS; thyroid diseases; 
neurological diseases/epilepsy; collagenosis; and cancer.
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is	also	a	relatively	new	instrument	for	analyzing	it;	few	studies	have	
used	WHODAS	among	women	of	reproductive	age,	with	no	reports	
on postpartum women, to the best of our knowledge. Other instru-
ments	have	been	used	to	assess	specific	conditions	such	as	depres-
sion, psychiatric morbidity, and anxiety.12–14 WHODAS scores among 
other	groups,	such	as	patients	with	Huntington’s	disease	or	dementia,	
showed	 that	 affected	 individuals	 have	 higher	WHODAS-	36	 scores,	
approximately three points higher than controls.15,16
In	 our	 retrospective	 cohort,	we	 found	 that	 there	was	 a	 statisti-
cally	significant	difference	in	WHODAS	scores	between	women	with	
and without SMM.7	However,	there	are	still	many	gaps	in	our	under-
standing of such results, as there is no baseline score or threshold to 
determine	the	clinical	significance	of	these	findings.	Hypertension	is	
an important cause of SMM17 and is responsible for over 70% of our 
cases	of	maternal	morbidity.	Our	analysis	showed	that	this	condition	
was	related	to	poor	functioning,	as	expressed	in	higher	WHODAS-	36	
scores. We can speculate that women with hypertension may expe-
rience	not	only	acute	complications	 (placental	abruption,	pulmonary	
edema, stroke), but also the need to control blood pressure postpar-
tum (and later in life) and the need to deal with the consequences of 
premature birth, since there is an increased risk of a medically indi-
cated preterm birth among these women.18 Most likely, these factors 
had	an	impact	on	functionality.	Another	study,	conducted	in	Malaysia	
using	a	different	psychometric	tool,	showed	that	women	who	expe-
rienced	SMM	had	 lower	 functional	 ability	 1	month	postpartum,	 but	
the	difference	disappeared	after	6	months.19 Unfortunately, we were 
unable to perform any subanalysis on women with chronic hyper-
tension	versus	gestational	hypertension	and	pre-	eclampsia.	The	dif-
ferences in WHODAS scores among these groups should be further 
explored and might provide an insight into the underlying mechanism 
of	impaired	functioning	postpartum.
Hemorrhagic	complications	did	not	reach	significant	levels	in	our	
WHODAS	analysis.	However,	we	cannot	draw	a	definitive	conclusion	
that	 this	 type	 of	morbidity	 does	 not	 lead	 to	 functional	 impairment	
owing to the limited number of cases in our sample. Nevertheless, 
we	could	speculate	that	if	hemorrhage	were	effectively	managed,	the	
impact	would	be	short-	term	until	the	body	re-	established	hematologic	
function,	whereas	our	duration	of	follow-	up	ranged	from	1	to	5	years.
The	 case	 definition	 in	 our	 study	 considered	 deliveries	 between	
2008 and 2012, which included an outbreak of pandemic H1N1 
influenza	 among	 pregnant	 women	 in	 our	 sample.	 This	 is	 reflected	
in	 the	number	of	 “other	morbidities,”	 as	 an	 indirect	 cause	of	mater-
nal morbidity.20 Other indirect causes of morbidity are increasing in 
Brazil	 as	 part	 of	 the	 obstetric	 transition.	This	 phenomenon	 demon-
strates that low- and middle- income countries are experiencing what 
high- income countries have previously experienced: as direct causes 
of maternal death and morbidity decrease with the improvement of 
social	 and	 economic	 conditions,	 the	 relative	 proportion	 of	 indirect	
causes increases.21,22 Nonetheless, emerging economies such as Brazil 
must struggle simultaneously with both the diseases of high- income 
settings	(such	as	cardiac	disease	and	cancer),	and	those	mostly	present	
in	 low-	income	settings	 (such	as	HIV/AIDS	and	anemia).23	Evaluating	
the	impact	on	functionality	according	to	each	setting	is	important	for	
awareness	and	for	defining	public	health	priorities	for	women.
A	 limitation	 of	 our	 study	 is	 the	 broad	 postpartum	 period	 con-
sidered (1–5 years). Even though all of our previous analyses have 
included	time	since	delivery	as	an	independent	variable,	with	no	signif-
icant	differences	among	them,10 other factors that we did not account 
for	 could	 have	 impacted	women’s	WHODAS	 scores.	 Future	 studies	
should be performed within a narrower postpartum period to address 
this concern.
The	 current	 analysis	 can	 guide	 future	 studies	 toward	 specific	
morbidities	 and	 interventions	 to	 prevent	 disabilities.	 The	 study	 of	
TABLE  3 Mean,	median,	and	standard	deviation	for	
WHODAS- 36 total score among women with and without 
complications	during	pregnancy.
Median Mean SD P value
Complication 0.01
Any (n=417) 14.2 19.0 16.4
None (n=214) 8.7 14.2 13.3
Hemorrhage 0.09
Yes (n=55) 9.8 13.8 13.8
No (n=576) 13.0 17.7 15.7
Hypertensive disorders 0.004
Yes (n=223) 15.2 19.9 16.6
No (n=408) 12.0 16.0 14.9
Other	complications <0.001
Yes (n=379) 15.1 19.4 16.3
No (n=252) 9.5 14.4 13.9
TABLE  4 Mean	and	standard	deviation	on	each	domain	of	WHODAS-	36	according	to	the	different	groups.
Hypertensive disorders Hemorrhage Others P value
No. 223 55 379
Domain	1:	cognition 22.4 ± 17.8 16.4 ± 13.3 22.2 ± 18.6 0.07
Domain 2: mobility 17.4 ± 21.8 10.2 ± 19.7 16.0 ± 20.2 0.07
Domain 3: self- care 6.5 ± 13.2 4.4 ± 11.1 6.2 ± 13.2 0.57
Domain	4:	getting	along	with	people 15.3 ± 21.1 8.8 ± 14.1 15.1 ± 20.5 0.08
Domain	5:	household	activities 26.3 ± 29.2 18.1 ± 26.5 25.3 ± 28.6 0.16
Domain	6:	participation 23.8 ± 21.1 17.0 ± 17.6 23.6 ± 21.6 0.08
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long- term consequences of maternal morbidity beyond acute disease 
(such	as	increased	risk	of	cardiovascular	complications	in	women	with	
previous pre- eclampsia24) is very limited. However, there is a need to 
address	 these	 consequences,	 because	 a	 mother’s	 impairments	 can	
impact	 the	whole	 family	 and	 future	 pregnancies.	The	findings	 high-
light	the	need	for	family	health	practitioners	to	incorporate	continuing	
medical	care,	even	after	recovery	from	the	acute	effects	of	pregnancy	
and	delivery.	WHODAS	is	a	potential	tool	for	this	endeavor	and	may	
be	able	to	guide	interventions	in	the	near	future.
Hypertensive	and	other	complications	 (mostly	 indirect	causes	of	
morbidity),	but	not	hemorrhagic	complications,	were	associated	with	
significantly	 increased	WHODAS-	36	scores.	Women	with	hyperten-
sive	 complications	 during	 pregnancy	 had	 the	 highest	WHODAS-	36	
scores. Future studies should establish the normality ranges of 
WHODAS-	36	score	in	obstetric	populations	and	compare	other	psy-
chometric	scales	with	WHODAS-	36	in	these	populations.
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